about
Mesoblast Ltd is a biotechnology company. It uses its proprietary technology platform to develop and commercialize allogeneic cellular medicines to treat complex diseases resistant to conventional standards of care and where inflammation plays a cent...
Read More
11.25
0.14
(1.26%)
56,097
XNAS Volume
XNAS 14 Jul, 2025 11:41 AM (EDT)
Not Eligible
Expensive Valuation
Technically Bearish
Mesoblast Ltd - ADR Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..